Reoperative pancreaticoduodenectomy for periampullary carcinoma

American Journal of Surgery

Volumn 172, Issue 5, 1996, Pages 432-438

  Robinson, Emily K ^a   Lee, Jeffrey E ^a   Lowy, Andrew M ^a   Fenoglio, Claudia J ^a   Pisters, Peter W T ^a   Evans, Douglas B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; INTESTINE RESECTION; PANCREAS CARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; TREATMENT OUTCOME;

AMPULLA OF VATER; COMMON BILE DUCT NEOPLASMS; HUMANS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; REOPERATION;

EID: 0030296631     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(96)00218-8     Document Type: Article

References (25)

1. 1. Fuhrman GM, Chamsangavej C, Abbruzzese JL, et al. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg. 1994;167:104-113.
2. 2. Robins DB, Katz RL, Evans DB, et al. Fine-needle aspiration of the pancreas: in quest of accuracy. Acta Cytol. 1995;39:1-10.
3. 3. Sung JJY, Chung S. Endoscopic stenting for palliation of malignant biliary obstruction. A review of progress in the last 15 years. Dig Dis Sci. 1995;40:1167-1173.
4. 4. Evans DB, Winchester DJ, Lee JE. Laparoscopic cholecystojejunostomy. In: MacFadyen BV, Ponsky JL, eds. Operative Laparoscopy and Thoracoscopy. New York: Raven Press, 1996;343-358.
5. 5. Evans DB, Staley CA, Lee JE, et al. Adenocarcinoma of the pancreas: recent controversies, current management, and future therapies. GI Cancer. 1996;1:149-161.
6. 6. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin. 1996;46:19.
7. 7. Rooij PD, Rogatko A, Bennan MF. Evaluation of palliative surgical procedures in unresectable pancreatic cancer. Br J Surg. 1991;78:1053-1058.
8. 8. Lillemoe KD, Sauter PK, Pitt HA, et al. Current status of surgical palliation of periampullary carcinoma. Surg Gynecol Obstet. 1993;176:1-10.
9. 9. Tyler DS, Evans DB. Reoperative pancreaticoduodenectomy. Ann Surg. 1994;2:211-221.
10. 10. Staley CA, Lee JE, Cleary KR, et al. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therpy for adenocarcinoma of the pancreatic head. Am J Surg. 1996;171:118-125.
11. 11. Evans DB, Lee JE, Pisters PWT. Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy for cancer. In: Nyhus LM, Baker RJ, Fischer JF, eds. Mastery of Surgery. 3rd ed. Boston: Little, Brown and Co.
12. 12. Evans DB, Termuhlen PM, Byrd DR, et al. Intraoperative radiation therapy following pancreaticoduodenectomy. Ann Surg. 1993;218:54-60.
13. 13. Staley CA, Cleary KA, Abbruzzese JA, et al. Need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas. 1996;12:373-380.
14. 14. Gastrointestinal Tumor Study Group. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. Ann Surg. 1979;189:205-208.
15. 15. Klempnauer J, Ridder GJ, Bektas H, Pichlmayr R. Surgery for exocrine pancreatic cancer - who are the 5-and 10-year survivors? Oncology. 1995;52:353-359.
16. 16. Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg. 1995;221:59-66.
17. 17. Willet CG, Lewandrowski K, Warshaw AL, et al. Resection margins in carcinoma of the head of the pancreas: implications for radiation therapy. Ann Surg. 1993;217:144-148.
18. 18. Yeo CJ, Cameron JL, Lillemore KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg. 1995;221:721-733.
19. 19. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993;165:68-73.
20. 20. Trede M, Schwall G, Saeger H. Survival after pancreaticoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg. 1990;211:447-458.
21. 21. Alvarez C, Livingston EH, Ashley SW, et al. Cost-benefit analysis of work-up for pancreatic cancer. Am J Surg. 1993;165:53-60.
22. 22. Cusack JC, Furhman GM, Lee JE, Evans, DB. Management of unsuspected tumor invasion of the superior mesenteric-portal venous confluence at the time of pancreaticoduodenectomy. Am J Surg. 1994;168:352-354.
23. 23. Fuhrman GM, Leach SD, Staley CA, et al. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Ann Surg. 1996;223:154-162.
24. 24. Evans DB, Lee JE, Leach SD, et al. Vascular resection and intraoperative radiation therapy during pancreaticoduodenectomy: rationale and technique. Adv Surg. 1996;29:235-262.
25. 25. Leach SD, Lowy AM, Fuhrman GM, et al. Pancreatic malignancy involving the superior mesenteric-portal vein confluence is not a contraindication to pancreaticoduodenectomy. Gastroenterology. 1995;108:A1228.